Skip to Content
MilliporeSigma
All Photos(1)

Documents

Y0000553

Doxazosin mesilate

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Doxazosin mesylate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate, Doxazosin methanesulfonate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C23H25N5O5 · CH3SO3H
CAS Number:
77883-43-3
Molecular Weight:
547.58
MDL number:
MFCD00216023
UNSPSC Code:
41116107
PubChem Substance ID:
329831016
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

doxazosin

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

CS(O)(=O)=O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4

InChI

1S/C23H25N5O5.CH4O3S/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20;1-5(2,3)4/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26);1H3,(H,2,3,4)

InChI key

VJECBOKJABCYMF-UHFFFAOYSA-N

Gene Information

human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Doxazosin mesilate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem/physiol Actions

α1-adrenoceptor antagonist; relaxes smooth muscles of the prostate

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

Y0000551

Doxazosin impurity D, European Pharmacopoeia (EP) Reference Standard

Y0000552

Doxazosin impurity F, European Pharmacopoeia (EP) Reference Standard

1225419

Doxazosin mesylate, United States Pharmacopeia (USP) Reference Standard

1225463

Doxazosin Related Compound D, United States Pharmacopeia (USP) Reference Standard

1225474

Doxazosin Related Compound E, United States Pharmacopeia (USP) Reference Standard

1225441

Doxazosin Related Compound B, United States Pharmacopeia (USP) Reference Standard

1225452

Doxazosin Related Compound C, United States Pharmacopeia (USP) Reference Standard

1225485

Doxazosin Related Compound F, United States Pharmacopeia (USP) Reference Standard

1225420

Doxazosin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1225496

Doxazosin Related Compound G, United States Pharmacopeia (USP) Reference Standard

PHR2954

Doxazosin Related Compound F, pharmaceutical secondary standard, certified reference material

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tanju Keten et al.
Urology, 85(1), 189-194 (2014-12-23)
To compare the efficacy of 4 mg and 8 mg doxazosin XL treatments in patients with benign prostatic hyperplasia-related lower urinary tract symptoms and determine the efficiency of 8 mg in those patients with inadequate response to 4 mg. A

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service